Linuo Pharmaceuticals announced that the fourth extraordinary shareholders' meeting of the company in 2026 considered and passed a number of proposals, such as issuing overseas listed shares and listing on the main board of the Hong Kong Stock Exchange, the issuance and listing plan, the use of funds raised, the rollover profit distribution plan, authorized the board of directors to handle related matters, the company's articles of association and related systems applicable after the H share listing, the election of independent directors, and amendments to the company's articles of association. There were no cases of rejection of the proposals at this shareholders' meeting.

Linuo Pharmaceuticals announced that the fourth extraordinary shareholders' meeting of the company in 2026 considered and passed a number of proposals, such as issuing overseas listed shares and listing on the main board of the Hong Kong Stock Exchange, the issuance and listing plan, the use of funds raised, the rollover profit distribution plan, authorized the board of directors to handle related matters, the company's articles of association and related systems applicable after the H share listing, the election of independent directors, and amendments to the company's articles of association. There were no cases of rejection of the proposals at this shareholders' meeting.